The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
S.L.E. Lupus Foundation
330 Seventh Avenue
New York, NY 10001
The S.L.E. Lupus Foundation is headquartered in New York City and has a West Coast division in Los Angeles. Through public service campaigns, public education programs and community outreach, the Foundation promotes early diagnosis of lupus and provides support especially in disadvantaged neighborhoods of New York City and Los Angeles. The Foundation vigorously addresses racial disparities in lupus through its community based model programs demonstrating the effective management of chronic disease among minority women. The Foundation funds lupus research grants and fellowship awards for new investigators in the New York region and in southern California, and in partnership with the Lupus Research Institute, supports innovative novel research nationwide.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.